Fulcrum Therapeutics (FULC) Shares Issued (2018 - 2026)

Fulcrum Therapeutics (FULC) has 9 years of Shares Issued data on record, last reported at $21000.0 in Q1 2026.

  • On a quarterly basis, Shares Issued changed N/A to $21000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $4.2 million, a 282.47% increase, with the full-year FY2025 number at $4.2 million, up 51.75% from a year prior.
  • Shares Issued reached $21000.0 in Q1 2026 per FULC's latest filing, down from $3.8 million in the prior quarter.
  • Over the last five years, Shares Issued for FULC hit a ceiling of $3.8 million in Q4 2025 and a floor of $21000.0 in Q1 2026.
  • A 5-year average of $748666.7 and a median of $287000.0 in 2023 define the central range for Shares Issued.
  • Peak YoY movement for Shares Issued: tumbled 96.08% in 2022, then soared 4480.72% in 2025.
  • Tracing FULC's Shares Issued over 5 years: stood at $267000.0 in 2022, then increased by 7.49% to $287000.0 in 2023, then crashed by 71.08% to $83000.0 in 2024, then skyrocketed by 4480.72% to $3.8 million in 2025, then plummeted by 99.45% to $21000.0 in 2026.
  • Business Quant data shows Shares Issued for FULC at $21000.0 in Q1 2026, $3.8 million in Q4 2025, and $64000.0 in Q3 2025.